{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:17:15Z","timestamp":1764173835128},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T00:00:00Z","timestamp":1344643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11060-012-0950-0","type":"journal-article","created":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T07:18:02Z","timestamp":1344583082000},"page":"49-57","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients"],"prefix":"10.1007","volume":"110","author":[{"given":"Raimundo M.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanny R.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France K. N.","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia D. L.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina R. T.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana C.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia M.","family":"Lamar\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rommel R.","family":"Burbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,11]]},"reference":[{"issue":"4","key":"950_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1158\/1078-0432.CCR-07-2072","volume":"14","author":"A Rossi","year":"2008","unstructured":"Rossi A, Caracciolo V, Russo G, Reiss K, Giordano A (2008) Medulloblastoma: from molecular pathology to therapy. Clin Cancer Res 14(4):971\u2013976. doi: 10.1158\/1078-0432.CCR-07-2072","journal-title":"Clin Cancer Res"},{"issue":"2","key":"950_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2009.02.002","volume":"71","author":"AA Brandes","year":"2009","unstructured":"Brandes AA, Franceschi E, Tosoni A, Reni M, Gatta G, Vecht C, Kortmann RD (2009) Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET). Crit Rev Oncol\/Hematol 71(2):165\u2013179. doi: 10.1016\/j.critrevonc.2009.02.002","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"5","key":"950_CR3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2000.18.5.1027","volume":"18","author":"MA Grotzer","year":"2000","unstructured":"Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM, Trojanowski JQ (2000) TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol 18(5):1027\u20131035","journal-title":"J Clin Oncol"},{"issue":"10","key":"950_CR4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27(10):1627\u20131636. doi: 10.1200\/JCO.2008.17.9432","journal-title":"J Clin Oncol"},{"issue":"4","key":"950_CR5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2990.2005.00664.x","volume":"31","author":"J Pizem","year":"2005","unstructured":"Pizem J, Cort A, Zadravec-Zaletel L, Popovic M (2005) Survivin is a negative prognostic marker in medulloblastoma. Neuropathol Appl Neurobiol 31(4):422\u2013428. doi: 10.1111\/j.1365-2990.2005.00664.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"22","key":"950_CR6","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","volume":"10","author":"A Ray","year":"2004","unstructured":"Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 10(22):7613\u20137620. doi: 10.1158\/1078-0432.CCR-04-0499","journal-title":"Clin Cancer Res"},{"issue":"8","key":"950_CR7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1200\/JCO.2009.23.5952","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Baskin B, Shago M, Alon N, Taylor MD, Ray PN, Bouffet E, Malkin D, Hawkins C (2010) Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations. J Clin Oncol 28(8):1345\u20131350. doi: 10.1200\/JCO.2009.23.5952","journal-title":"J Clin Oncol"},{"issue":"12","key":"950_CR8","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","volume":"24","author":"MC Thompson","year":"2006","unstructured":"Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24(12):1924\u20131931. doi: 10.1200\/JCO.2005.04.4974","journal-title":"J Clin Oncol"},{"issue":"3","key":"950_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/humu.10172","volume":"21","author":"J Benard","year":"2003","unstructured":"Benard J, Douc-Rasy S, Ahomadegbe JC (2003) TP53 family members and human cancers. Hum Mutat 21(3):182\u2013191. doi: 10.1002\/humu.10172","journal-title":"Hum Mutat"},{"issue":"6","key":"950_CR10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 28(6):622\u2013629. doi: 10.1002\/humu.20495","journal-title":"Hum Mutat"},{"issue":"35","key":"950_CR11","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1200\/JCO.2010.31.1670","volume":"28","author":"E Pfaff","year":"2010","unstructured":"Pfaff E, Remke M, Sturm D, Benner A, Witt H, Milde T, von Bueren AO, Wittmann A, Sch\u00f6ttler A, Jorch N, Graf N, Kulozik AE, Witt O, Scheurlen W, von Deimling A, Rutkowski S, Taylor MD, Tabori U, Lichter P, Korshunov A, Pfister SM (2010) TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 28(35):5188\u20135196. doi: 10.1200\/JCO.2010.31.1670","journal-title":"J Clin Oncol"},{"issue":"12","key":"950_CR12","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1200\/JCO.2010.33.8590","volume":"29","author":"JC Lindsey","year":"2011","unstructured":"Lindsey JC, Hill RM, Megahed H, Lusher ME, Schwalbe EC, Cole M, Hogg TL, Gilbertson RJ, Ellison DW, Bailey S, Clifford SC (2011) TP53 mutations in favorable-risk Wnt\/wingless-subtype medulloblastomas. J Clin Oncol 29(12):e344\u2013e346. doi: 10.1200\/JCO.2010.33.8590","journal-title":"J Clin Oncol"},{"issue":"1","key":"950_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11060-011-0648-8","volume":"106","author":"M Gessi","year":"2012","unstructured":"Gessi M, von Bueren AO, Rutkowski S, Pietsch T (2012) p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. J Neurooncol 106(1):135\u2013141. doi: 10.1007\/s11060-011-0648-8","journal-title":"J Neurooncol"},{"issue":"9","key":"950_CR14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4161\/cc.6.9.4211","volume":"6","author":"A Efeyan","year":"2007","unstructured":"Efeyan A, Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6(9):1006\u20131010","journal-title":"Cell Cycle"},{"key":"950_CR15","doi-asserted-by":"crossref","unstructured":"Dumont P, Leu JI, Della Pietra AC, 3rd, George DL, Murphy M (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nature Genet 33(3):357\u2013365. doi: 10.1038\/ng1093","DOI":"10.1038\/ng1093"},{"issue":"5","key":"950_CR16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ncb1123","volume":"6","author":"JI Leu","year":"2004","unstructured":"Leu JI, Dumont P, Hafey M, Murphy ME, George DL (2004) Mitochondrial p53 activates Bak and causes disruption of a Bak\u2013Mcl1 complex. Nat Cell Biol 6(5):443\u2013450. doi: 10.1038\/ncb1123","journal-title":"Nat Cell Biol"},{"issue":"1","key":"950_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4238\/vol8-1gmr518","volume":"8","author":"LO Almeida","year":"2009","unstructured":"Almeida LO, Custodio AC, Pinto GR, Santos MJ, Almeida JR, Clara CA, Rey JA, Casartelli C (2009) Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors. Genet Mol Res 8(1):8\u201318","journal-title":"Genet Mol Res"},{"issue":"4","key":"950_CR18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.wnl.0000341277.74885.ec","volume":"72","author":"S Hallani El","year":"2009","unstructured":"El Hallani S, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, Laigle-Donadey F, Rodero M, Chinot O, Thillet J, Hoang-Xuan K, Delattre JY, Sanson M (2009) TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology 72(4):332\u2013336. doi: 10.1212\/01.wnl.0000341277.74885.ec","journal-title":"Neurology"},{"issue":"2","key":"950_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yexmp.2010.11.002","volume":"90","author":"P Jha","year":"2011","unstructured":"Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, Kumar G, Singh M, Mahapatra AK, Sarkar C (2011) TP53 polymorphisms in gliomas from Indian patients: study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp Mol Pathol 90(2):167\u2013172. doi: 10.1016\/j.yexmp.2010.11.002","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"950_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1750-3639.2008.00170.x","volume":"19","author":"I Zawlik","year":"2009","unstructured":"Zawlik I, Kita D, Vaccarella S, Mittelbronn M, Franceschi S, Ohgaki H (2009) Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain Pathol 19(2):188\u2013194. doi: 10.1111\/j.1750-3639.2008.00170.x","journal-title":"Brain Pathol"},{"issue":"2","key":"950_CR21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/cncr.10189","volume":"94","author":"CG Eberhart","year":"2002","unstructured":"Eberhart CG, Kepner JL, Goldthwaite PT, Kun LE, Duffner PK, Friedman HS, Strother DR, Burger PC (2002) Histopathologic grading of medulloblastomas: a Pediatric Oncology Group Study. Cancer 94(2):552\u2013560. doi: 10.1002\/cncr.10189","journal-title":"Cancer"},{"issue":"2","key":"950_CR22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97\u2013109. doi: 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"issue":"1","key":"950_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4238\/vol7-1gmr415","volume":"7","author":"GR Pinto","year":"2008","unstructured":"Pinto GR, Yoshioka FK, Silva RL, Clara CA, Santos MJ, Almeida JR, Burbano RR, Rey JA, Casartelli C (2008) Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet Mol Res 7(1):207\u2013216","journal-title":"Genet Mol Res"},{"issue":"7","key":"950_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2010.03.004","volume":"20","author":"Z Feng","year":"2010","unstructured":"Feng Z, Levine AJ (2010) The regulation of energy metabolism and the IGF-1\/mTOR pathways by the p53 protein. Trends Cell Biol 20(7):427\u2013434. doi: 10.1016\/j.tcb.2010.03.004","journal-title":"Trends Cell Biol"},{"issue":"1","key":"950_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","volume":"100","author":"FC Parra","year":"2003","unstructured":"Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD (2003) Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100(1):177\u2013182. doi: 10.1073\/pnas.0126614100","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"950_CR26","first-page":"59","volume":"51","author":"E Biros","year":"2002","unstructured":"Biros E, Kalina I, Kohut A, Bogyiova E, Salagovic J, Sulla I (2002) Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients. Physiol Res\/Acad Sci Bohemoslov 51(1):59\u201364","journal-title":"Physiol Res\/Acad Sci Bohemoslov"},{"issue":"1\u20132","key":"950_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molbrainres.2005.02.016","volume":"137","author":"P Parhar","year":"2005","unstructured":"Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW (2005) Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Brain Res Mol Brain Res 137(1\u20132):98\u2013103. doi: 10.1016\/j.molbrainres.2005.02.016","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"950_CR28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2007.08.019","volume":"180","author":"V Lima-Ramos","year":"2008","unstructured":"Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A, Amorim J, Lopes JM, Reis RM (2008) TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 180(1):14\u201319. doi: 10.1016\/j.cancergencyto.2007.08.019","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"950_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/humu.20055","volume":"24","author":"Y Wang","year":"2004","unstructured":"Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Trop\u00e9 CG, Abeler VM, Nesland JM, B\u00f8rresen-Dale AL, Helland A (2004) Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma. Hum Mutat 24(1):21\u201334. doi: 10.1002\/humu.20055","journal-title":"Hum Mutat"},{"key":"950_CR30","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","volume":"22","author":"A Ray","year":"2004","unstructured":"Ray A, Ho M, Ma J, Parkes RK, Mainprize TG, Ueda S, McLaughlin J, Bouffet E, Rutka JT, Hawkins CE (2004) A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res 22:7613\u20137620. doi: 10.1158\/1078-0432.CCR-04-0499","journal-title":"Clin Cancer Res"},{"issue":"11","key":"950_CR31","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","volume":"29","author":"PA Northcott","year":"2011","unstructured":"Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD (2011) Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 29(11):1408\u20131414. doi: 10.1200\/JCO.2009.27.4324","journal-title":"J Clin Oncol"},{"key":"950_CR32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-010-0726-6","volume":"3","author":"DW Ellison","year":"2010","unstructured":"Ellison DW (2010) Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease. Acta Neuropathol 3:305\u2013316. doi: 10.1007\/s00401-010-0726-6","journal-title":"Acta Neuropathol"},{"key":"950_CR33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.22339","volume":"3","author":"K Hoff von","year":"2010","unstructured":"von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, Rutkowski S (2010) Large cell\/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatr Blood Cancer 3:369\u2013376. doi: 10.1002\/pbc.22339","journal-title":"Pediatr Blood Cancer"},{"key":"950_CR34","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1200\/JCO.2010.30.2299","volume":"33","author":"S Rutkowski","year":"2010","unstructured":"Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, Giangaspero F, Ellison DW, Garre ML, Biassoni V, Grundy RG, Finlay JL, Dhall G, Raquin MA, Grill J (2010) Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol 33:4961\u20134968. doi: 10.1200\/JCO.2010.30.2299","journal-title":"J Clin Oncol"},{"key":"950_CR35","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-07-4159","volume":"13","author":"T Haas de","year":"2008","unstructured":"de Haas T, Hasselt N, Troost D, Caron H, Popovic M, Zadravec-Zaletel L, Grajkowska W, Perek M, Osterheld MC, Ellison D, Baas F, Versteeg R, Kool M (2008) Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression. Clin Cancer Res 13:4154\u20134160. doi: 10.1158\/1078-0432.CCR-07-4159","journal-title":"Clin Cancer Res"},{"key":"950_CR36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol 17:832\u2013845","journal-title":"J Clin Oncol"},{"key":"950_CR37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejca.2004.12.017","volume":"41","author":"RE Taylor","year":"2005","unstructured":"Taylor RE, Bailey CC, Robinson KJ, Weston CL, Walker DA, Ellison D, Ironside J, Pizer BL, Lashford LS (2005) Outcome for patients with metastatic (M2\u20133) medulloblastoma treated with SIOP\/UKCCSG PNET-3 chemotherapy. Eur J Cancer 41:727\u2013734. doi: 10.1016\/j.ejca.2004.12.017","journal-title":"Eur J Cancer"},{"key":"950_CR38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/02688690903121807","volume":"23","author":"BL Pizer","year":"2009","unstructured":"Pizer BL, Clifford SC (2009) The potential impact of tumor biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials. Br J Neurosurg 23:364\u2013375. doi: 10.1080\/02688690903121807","journal-title":"Br J Neurosurg"},{"key":"950_CR39","unstructured":"Kweekel DM, Van der Straaten T, Koopman M, Meijer GA, Nortier JW, Cornelis JA, Gelderblom H, Guchelaar HJ (2010) Comparison of genetic polymorphisms in DNA isolated from blood and paraffin embedded colorectal cancer tissue. https:\/\/openaccess.leidenuniv.nl\/bitstream\/handle\/1887\/13820\/03.pdf . Accessed 10 Feb 2012"},{"issue":"2","key":"950_CR40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3802\/jgo.2011.22.2.110","volume":"22","author":"JZ Cerne","year":"2011","unstructured":"Cerne JZ, Pohar-Perme M, Novakovic S, Frkovic-Grazio S, Stegel V, Gersak K (2011) Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer. J Gynecol Oncol 22(2):110\u2013119. doi: 10.3802\/jgo.2011.22.2.110","journal-title":"J Gynecol Oncol"},{"issue":"8","key":"950_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00008571-200308000-00008","volume":"13","author":"JM Rae","year":"2003","unstructured":"Rae JM, Cordero KE, Scheys JO, Lippman ME, Flockhart DA, Johnson MD (2003) Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples. Pharmacogenetics 13(8):501\u2013507. doi: 10.1097\/00008571-200308000-00008","journal-title":"Pharmacogenetics"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0950-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-012-0950-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-012-0950-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:17:38Z","timestamp":1559362658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-012-0950-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s11060-012-0950-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,11]]}}}